

Blocking a Cell Receptor Could Protect Against Deadly Disease. Hantaviruses cause severe and sometimes fatal respiratory infections, but…

SALT LAKE CITY, Nov. 5, 2018 /PRNewswire/ — Recursion Pharmaceuticals, a biotechnology company that combines artificial intelligence (AI), experimental biology, and…

Salt Lake City, UT, Thursday, October 18, 2018 –Mountain Pacific Venture Fund announced today its investment in Decoy…

SALT LAKE CITY, UT (September 28, 2018) – BioUtah today announced that the board of directors has selected…

Dr. Shuren will take the stage as the luncheon keynote at the 2018 BioUtah Utah Life Sciences Summit,…

Registration opens today for the 2018 BioUtah ULSS, offering early bird discounts. Preliminary speaker line-up includes notable business…

On November 1, BioUtah will be holding its 9th annual Utah Life Sciences Summit (ULSS). This is the…

BioUtah is pleased to share with you the newly released study by the Kem C. Gardner Policy Institute…

Salt Lake City, August 1, 2018: Mountain Pacific Venture Partners, a Salt Lake City-based venture capital firm, has…

FOR IMMEDIATE RELEASE July 25, 2018 BioUtah Statement on U.S. House of Representatives Passage of Legislation to Permanently…

Please join us and Global Genes on Saturday, June 30th for RARE on the Road Rare Disease Leadership…

Biomerics LLC, a medical device contract manufacturer headquartered in Salt Lake City, UT is pleased to announce the…